Currency Rules Restrict Expansion Plans

The value of medicines exported from Bangladesh is expected to increase from US$51.7mn in 2009 to US$174.9mn in 2019, equating to an impressive compound annual growth rate (CAGR) of 27.6%. Despite this enviable trajectory, BMI notes that the sector is being held back by restrictive measures imposed by the country's central bank.

To read the full article, please choose one of the following options: